AVE Science & Technology Co

AVE Science & Technology Co Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of AVE Science & Technology Co (688067.SS) as of Nov 16, 2026 is 157.39. In the previous year, Cash Conversion Cycle (CCC) was 192.90 — a change of -18.41% (lower).

Cash Conversion Cycle

157.39

YoY

-18.41%

Last updated:

Cash Conversion Cycle (CCC) of AVE Science & Technology Co is 2025 157.39 . Cash Conversion Cycle (CCC) of AVE Science & Technology Co was 2024 192.90 . It decreases by -18.41% lower compared to the previous year.

The AVE Science & Technology Co Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
175.75 CNY
Jan 1, 2019
163.30 CNY
Jan 1, 2020
156.37 CNY
Jan 1, 2021
164.96 CNY
Jan 1, 2022
149.33 CNY
Jan 1, 2023
163.53 CNY
Jan 1, 2024
192.90 CNY
Jan 1, 2025
157.39 CNY
The AVE Science & Technology Co Cash Conversion Cycle history
YEARCash Conversion CycleYoY
157.39-18.41%
192.90+17.96%
163.53+9.51%
149.33-9.47%
164.96+5.49%
156.37-4.25%
163.30-7.08%
175.75-4.00%
183.07+30.37%
140.42-15.65%
166.48+3.15%
161.39—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AVE Science & Technology Co Stock analysis

What does AVE Science & Technology Co do? AVE Science & Technology Co., Ltd. generates revenue through the research, development, production, sale, and service of clinical testing and analysis instruments. Its main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables. These products are primarily sold to inspection departments within medical and health institutions in both domestic and overseas markets. The company serves healthcare facilities that require diagnostic equipment for laboratory testing and patient care. The firm's product portfolio targets healthcare institutions seeking advanced diagnostic tools for efficient clinical analysis. By focusing on specialized instruments like urine and stool analyzers, AVE Science & Technology addresses specific needs in medical testing departments. The company's domestic and international distribution channels ensure broad market access for its diagnostic solutions. AVE Science & Technology's revenue streams are derived from the sale of its comprehensive range of clinical testing instruments and related consumables. The company's domestic market presence and overseas sales contribute to its overall business performance. Its products support routine diagnostic procedures across various healthcare settings, driving consistent demand for its equipment and reagents. AVE Science & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AVE Science & Technology Co stock

Cash Conversion Cycle (CCC) of AVE Science & Technology Co is 157.39 in 2025.

Cash Conversion Cycle (CCC) of AVE Science & Technology Co changed from 192.90 to 157.39, representing a -18.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) AVE Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s AVE Science & Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — AVE Science & Technology Co

All Key Metrics — AVE Science & Technology Co